Shane Shircliff Sells 30,000 Shares of CanAlaska Uranium (CVE:CVV) Stock

Key Points

• Director Shane Shircliff sold 30,000 shares on April 22 at an average price of C$0.73 for C$21,900, cutting his stake by 27.27% to 80,000 shares (valued at about C$58,400).
• Stock performance: shares fell 3.5% to C$0.69 with 230,205 shares traded (below the 592,944 average); market cap is roughly C$150.8M and the one‑year range is C$0.51–C$1.26 with 50/200‑day moving averages around C$0.77/C$0.76.
• Analyst view: Canaccord Genuity set a C$1.35 price target and a "moderate buy" rating, and MarketBeat shows a consensus "Buy" with an average target of C$1.35.

CanAlaska Uranium Ltd. (CVE:CVV - Get Free Report) Director Shane Shircliff sold 30,000 shares of the business's stock in a transaction dated Wednesday, April 22nd. The stock was sold at an average price of C$0.73, for a total transaction of C$21,900.00. Following the transaction, the director owned 80,000 shares in the company, valued at approximately C$58,400. This trade represents a 27.27% decrease in their ownership of the stock.

CanAlaska Uranium Trading Down 3.5%

Shares of CanAlaska Uranium stock traded down C$0.03 on Friday, reaching C$0.69. 230,205 shares of the stock were exchanged, compared to its average volume of 592,944. CanAlaska Uranium Ltd. has a 1-year low of C$0.51 and a 1-year high of C$1.26. The business has a fifty day moving average price of C$0.77 and a two-hundred day moving average price of C$0.76. The firm has a market capitalization of C$150.78 million, a PE ratio of -7.61 and a beta of 0.11.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group set a C$1.35 price objective on shares of CanAlaska Uranium and gave the stock a "moderate buy" rating in a report on Monday, January 19th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of "Buy" and a consensus target price of C$1.35.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.